High-intensity focused ultrasound-a needleless management for osteoid osteoma: a systematic review.

Q1 Medicine

MUSCULOSKELETAL SURGERY Pub Date : 2024-03-01 Epub Date: 2023-12-27 DOI:10.1007/s12306-023-00801-1

K Ciatawi, I W S Dusak, I G E Wiratnaya

{"title":"High-intensity focused ultrasound-a needleless management for osteoid osteoma: a systematic review.","authors":"K Ciatawi, I W S Dusak, I G E Wiratnaya","doi":"10.1007/s12306-023-00801-1","DOIUrl":null,"url":null,"abstract":"<p><p>Osteoid osteoma is one of the most frequent benign musculoskeletal neoplasm. Radiofrequency ablation is the method of choice for non-conservative treatment of osteoid osteoma. Recently, high-intensity focused ultrasound (HIFU) has been proposed as a safer option. The objective of this study is to review the efficacy and side effects of HIFU in the management of osteoid osteoma. A comprehensive search was conducted in PubMed, Science Direct, and Clinical Key until June 30, 2022. Demographic data, baseline characteristics, success rates, pre- and post-procedure pain scores, recurrences, and complications were recorded. Eleven studies were included in this systematic review. Pooled analysis that involved 186 subjects resulted in an overall success rate of 91.94%. Recurrence was reported in two studies, in which it occurred in 4/177 (2.26%) subjects. Skin burn was found in 1 (0.54%) patients. No major or other complications were reported. Three studies compared the success rate of HIFU and RFA. Success rate was slightly higher in the RFA group with insignificant difference (p = 0.15). High-intensity focused ultrasound showed promising results. It offers a safer treatment approach for osteoid osteoma, especially in children, and can be considered for recalcitrant cases after RFA. Nonetheless, more studies are expected in the future.</p>","PeriodicalId":18875,"journal":{"name":"MUSCULOSKELETAL SURGERY","volume":" ","pages":"21-30"},"PeriodicalIF":0.0000,"publicationDate":"2024-03-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"MUSCULOSKELETAL SURGERY","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1007/s12306-023-00801-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/12/27 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Osteoid osteoma is one of the most frequent benign musculoskeletal neoplasm. Radiofrequency ablation is the method of choice for non-conservative treatment of osteoid osteoma. Recently, high-intensity focused ultrasound (HIFU) has been proposed as a safer option. The objective of this study is to review the efficacy and side effects of HIFU in the management of osteoid osteoma. A comprehensive search was conducted in PubMed, Science Direct, and Clinical Key until June 30, 2022. Demographic data, baseline characteristics, success rates, pre- and post-procedure pain scores, recurrences, and complications were recorded. Eleven studies were included in this systematic review. Pooled analysis that involved 186 subjects resulted in an overall success rate of 91.94%. Recurrence was reported in two studies, in which it occurred in 4/177 (2.26%) subjects. Skin burn was found in 1 (0.54%) patients. No major or other complications were reported. Three studies compared the success rate of HIFU and RFA. Success rate was slightly higher in the RFA group with insignificant difference (p = 0.15). High-intensity focused ultrasound showed promising results. It offers a safer treatment approach for osteoid osteoma, especially in children, and can be considered for recalcitrant cases after RFA. Nonetheless, more studies are expected in the future.

查看原文本刊更多论文

高强度聚焦超声--治疗骨样骨瘤的无针疗法：系统综述。

骨样骨瘤是最常见的良性肌肉骨骼肿瘤之一。射频消融是非保守治疗类骨瘤的首选方法。最近，高强度聚焦超声（HIFU）被认为是一种更安全的选择。本研究旨在回顾 HIFU 治疗类骨瘤的疗效和副作用。截至 2022 年 6 月 30 日，我们在 PubMed、Science Direct 和 Clinical Key 上进行了全面搜索。研究记录了人口统计学数据、基线特征、成功率、治疗前后疼痛评分、复发率和并发症。本系统综述共纳入 11 项研究。对 186 名受试者进行了汇总分析，得出总体成功率为 91.94%。有两项研究报告了复发情况，其中 4/177 名受试者（2.26%）出现了复发。1例（0.54%）患者出现皮肤灼伤。没有重大或其他并发症的报道。三项研究比较了 HIFU 和 RFA 的成功率。RFA 组的成功率略高，但差异不显著（P = 0.15）。高强度聚焦超声显示出良好的效果。它为骨样骨瘤（尤其是儿童骨样骨瘤）提供了一种更安全的治疗方法，可考虑用于治疗 RFA 后的顽固病例。不过，未来还需要更多的研究。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

MUSCULOSKELETAL SURGERY Medicine-Surgery

CiteScore

4.50

自引率

0.00%

发文量

期刊介绍： Musculoskeletal Surgery – Formerly La Chirurgia degli Organi di Movimento, founded in 1917 at the Istituto Ortopedico Rizzoli, is a peer-reviewed journal published three times a year. The journal provides up-to-date information to clinicians and scientists through the publication of original papers, reviews, case reports, and brief communications dealing with the pathogenesis and treatment of orthopaedic conditions.An electronic version is also available at http://www.springerlink.com.The journal is open for publication of supplements and for publishing abstracts of scientific meetings; conditions can be obtained from the Editors-in-Chief or the Publisher.